We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 32

Boston Scientific prevails in securities fraud lawsuit

  • Winston & Strawn LLP
  • -
  • USA
  • -
  • August 22 2011

On August 15th, the First Circuit addressed what adverse events associated with medical devices an issuer must disclose, affirming the entry of summary judgment dismissing a Rule 10b-5 securities fraud lawsuit

Senate adopts food safety crime bill

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 22 2011

The U.S. Senate has approved a bill (S. 216) designed to “strengthen criminal penalties for companies that knowingly violate food safety standards and place tainted food products on the market,” according to the legislation’s sponsor, Senator Patrick Leahy (D-Vt

New Jersey Consumer Fraud Act

  • Day Pitney LLP
  • -
  • USA
  • -
  • September 13 2013

In a business-friendly decision, Perez v. Professionally Green, LLC, 214 N.J. ___ (2013), a unanimous New Jersey Supreme Court held yesterday that a

The enforcement heat increases and Stryker is just the latest

  • Faegre Baker Daniels
  • -
  • USA
  • -
  • October 30 2009

Recent statements by FDA and DOJ officials, including FDA Commissioner Hamburg, promised an increase in enforcement

Matrixx Securities fraud case could affect product liability law

  • Squire Patton Boggs
  • -
  • USA
  • -
  • December 10 2010

Sometimes the most significant changes in the law come from unexpected places

The top 5 corruption risks for pharmaceutical and medical device companies

  • LeClairRyan
  • -
  • USA
  • -
  • September 19 2012

Pharmaceutical and medical device companies are fast becoming the enforcement punching bag, eclipsing the long-suffering status of the oil and gas energy

Supreme Court grants cert to determine if plaintiff must prove materiality before certifying class in securities fraud class action

  • Porter Wright Morris & Arthur LLP
  • -
  • USA
  • -
  • June 12 2012

On Monday, June 11, 2012, the Supreme Court granted a Writ of Certiorari in Amgen, Inc. v. Connecticut Retirement Plans and Trust Funds, No. 11-1085 (U.S. Jun. 11, 2012) to decide whether, in a misrepresentation case under SEC Rule l0b-5, the court must require proof of materiality before certifying a plaintiff class based on the fraud-on-the-market theory (and whether the court must allow the defendants to present evidence rebutting the applicability of the fraud-on-the-market theory before certifying the class

Indictment of former GlaxoSmithKline in-house attorney highlights risks and provides lessons for handling document requests in government investigations

  • Jenner & Block
  • -
  • USA
  • -
  • November 23 2010

A former in-house counsel at pharmaceutical company GlaxoSmithKline ("GSK"), Lauren Stevens, was indicted earlier this month for obstruction of a proceeding, false statements, and falsifying or concealing documents for her role in responding to a document request from the Food and Drug Administration ("FDA"

EU political update 22 - 26 July 2013

  • Clifford Chance LLP
  • -
  • European Union
  • -
  • July 26 2013

On 17 July, the European Commission set out certain proposals aiming to improve Union-wide prosecution of criminals who defraud European Union

British man imprisoned in ‘Operation Singapore’ investigation

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • May 3 2011

The UK MHRA's 'Operation Singapore' investigation into the infiltration of counterfeit medicine into the UK's supply chain during five months in 2007 has concluded with a British man being sentenced to eight years imprisonment